Transfusion Clinical Trials

61 recruitingLast updated: May 13, 2026

There are 61 actively recruiting transfusion clinical trials across 22 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Tianjin, Tianjin Municipality, China, Boston, Massachusetts, United States, Nanning, Guangxi, China. Updated daily from ClinicalTrials.gov.


Transfusion Trials at a Glance

61 actively recruiting trials for transfusion are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 23 trials, with the heaviest enrollment activity in Tianjin, Boston, and Nanning. Lead sponsors running transfusion studies include Institute of Hematology & Blood Diseases Hospital, China, First Affiliated Hospital of Guangxi Medical University, and Boston Children's Hospital.

Browse transfusion trials by phase

Treatments under study

About Transfusion Clinical Trials

Looking for clinical trials for Transfusion? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transfusion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transfusion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 61 trials

Recruiting
Not Applicable

Against Chikungunya Virus and Neonatal Infection

TransfusionEncephalopathyNeonatal+1 more
Centre Hospitalier Universitaire de la Réunion60 enrolled2 locationsNCT07190560
Recruiting
Phase 3

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Surgical Blood LossTransfusion-dependent AnemiaAbdomen Disease
Ulrich Ronellenfitsch, MD850 enrolled2 locationsNCT06414031
Recruiting
Not Applicable

Oxygen Extraction-guided Transfusion

blood transfusion
Università degli Studi di Ferrara324 enrolled4 locationsNCT06102590
Recruiting
Phase 4

Antihistamine for Prevention of HTR After Blood Primed CPB

Blood Transfusion Associated Adverse Reactions
Kasr El Aini Hospital40 enrolled1 locationNCT07536152
Recruiting

Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion

TraumaThromboembolusMassive Blood Transfusion; Thrombocytopenia
Zeliha Alicikus4 enrolled2 locationsNCT07290634
Recruiting
Not Applicable

Neonatal Platelet Transfusion Threshold Trial

ThrombosisThrombocytopeniaNeonatal+4 more
NICHD Neonatal Research Network2,433 enrolled20 locationsNCT06676904
Recruiting
Phase 2

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals95 enrolled26 locationsNCT06421636
Recruiting
Not Applicable

Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage

Obstetric HemostasisIntravascular HemolysisMajor Obstetric Hemorrhage+2 more
Aswan University50 enrolled1 locationNCT07466719
Recruiting
Phase 4

Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes

CardiovascularRed Blood Cell TransfusionsSex Differences+3 more
Michelle Zeller11,082 enrolled8 locationsNCT06840756
Recruiting
Not Applicable

The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome

Twin to Twin Transfusion
Baylor College of Medicine216 enrolled1 locationNCT06829901
Recruiting

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

gastroschisisFetal deathPregnancy Loss+16 more
Medical College of Wisconsin30 enrolled2 locationsNCT03775954
Recruiting

Blood Storage Related Mortality and Adverse Effects in Trauma Patients

Transfusion Adverse ReactionBlood Product Transfusion for All ConditionsMajor trauma
Kocaeli City Hospital300 enrolled1 locationNCT07341139
Recruiting

Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department

Trauma Induced CoagulopathyTrauma CoagulopathyFibrinogen Deficiency+3 more
Erasmus Medical Center150 enrolled1 locationNCT07097337
Recruiting
Phase 1

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

Beta-ThalassemiaSickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)+1 more
Daniel Bauer10 enrolled1 locationNCT06647979
Recruiting
Not Applicable

Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile

PrematurePlacental Transfusion
Alexandria University160 enrolled1 locationNCT06812507
Recruiting

Pathogen-Reduced Platelet Concentrates: Experience in Routine Practice in Germany

Platelet transfusion
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen850 enrolled1 locationNCT07354672
Recruiting

Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

blood transfusionHeart SurgeryHemolysis
Boston Children's Hospital50 enrolled1 locationNCT06721455
Recruiting
Phase 2

Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

Transfusion-dependent β-thalassemia Patients
Rongrong Liu78 enrolled8 locationsNCT07338344
Recruiting

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

blood transfusionBlood Transfusion ComplicationBleeding+6 more
St. Antonius Hospital374 enrolled7 locationsNCT07309848
Recruiting
Not Applicable

Home Blood Transfusions

Acute Myeloid LeukemiaHematologic MalignancyMyelodysplastic Syndromes+1 more
Thomas Jefferson University30 enrolled1 locationNCT07121140